Coronary Artery Disease

Primary Care - Clinics in Office Practice

Volumn 40, Issue 1, 2013, Pages 1-16

  Hanson, Michele A ^a   Fareed, Mohammad Tariq ^a   Argenio, Sandra L ^b   Agunwamba, Akochi O ^a   Hanson, Teresa R ^c  

^a MAYO CLINIC   (United States)

^b MAYO CLINIC   (United States)

^c CREIGHTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Angina; Aspirin; Ischemia; Troponin

Indexed keywords

ACETYLSALICYLIC ACID; ATORVASTATIN; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CLOPIDOGREL; CREATINE KINASE MB; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GLYCERYL TRINITRATE; GROWTH FACTOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; MORPHINE; NITRATE; TISSUE PLASMINOGEN ACTIVATOR; TROPONIN;

ACUTE CORONARY SYNDROME; ACUTE HEART INFARCTION; AGE DISTRIBUTION; ANGINA PECTORIS; ANGIOCARDIOGRAPHY; CARDIOVASCULAR DISEASE; CARDIOVASCULAR MAGNETIC RESONANCE; CAUSE OF DEATH; CLINICAL FEATURE; CORONARY ARTERY CALCIUM SCORE; CORONARY ARTERY DISEASE; CORONARY ARTERY SPASM; CORONARY STENT; DRUG DOSE REDUCTION; DRUG MECHANISM; ELECTROCARDIOGRAPHY; EXERCISE TEST; FIBRINOLYTIC THERAPY; GOLD STANDARD; HEART CATHETERIZATION; HEART MUSCLE ISCHEMIA; HEART MUSCLE NECROSIS; HEART SUPRAVENTRICULAR ARRHYTHMIA; HUMAN; HYPERTENSION; HYPERTROPHIC CARDIOMYOPATHY; MINIMALLY INVASIVE CARDIAC SURGERY; MYOCARDIAL PERFUSION IMAGING; NON ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; NONHUMAN; OXYGEN SUPPLY; PATHOGENESIS; PERCUTANEOUS CORONARY INTERVENTION; POSTOPERATIVE HEMORRHAGE; POSTOPERATIVE INFECTION; PRIORITY JOURNAL; Q WAVE; RECOMMENDED DRUG DOSE; REVIEW; RISK ASSESSMENT; RISK FACTOR; RISK REDUCTION; SECONDARY PREVENTION; SEX RATIO; SILENT MYOCARDIAL ISCHEMIA; SMOOTH MUSCLE RELAXATION; ST SEGMENT; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; STABLE ANGINA PECTORIS; STEM CELL TRANSPLANTATION; SUDDEN DEATH; THROMBOCYTE AGGREGATION INHIBITION; TREATMENT CONTRAINDICATION; TREATMENT INDICATION; UNSTABLE ANGINA PECTORIS; VASODILATATION;

BIOLOGICAL MARKERS; CARDIAC CATHETERIZATION; CARDIOVASCULAR AGENTS; CORONARY ARTERY DISEASE; CREATINE KINASE, MB FORM; ELECTROCARDIOGRAPHY; EXERCISE TEST; HUMANS; MYOCARDIAL INFARCTION; MYOCARDIAL ISCHEMIA; PRIMARY HEALTH CARE; RISK ASSESSMENT; RISK FACTORS; STENTS; TROPONIN;

EID: 84873575343     PISSN: 00954543     EISSN: 1558299X     Source Type: Journal    
DOI: 10.1016/j.pop.2012.12.001     Document Type: Review

References (20)

1. Roger V.L., Go A.S., Lloyd-Jones D.M., et al. Executive summary: heart disease and stroke statistics-2012 update: a report from the American Heart Association. Circulation 2012, 124:188-197.
2. Gibbons RJ, Abrams J, Chatterjee K, et al. ACC/AHA 2002 guideline update for the management of patients with chronic stable angina. Available at: Accessed August 24, 2006. http://www.acc/org/qualityandscience/clinical/statements.htm.
3. Thygesen K., Alpert J.S., White H.D., Joint ESC/ACCF/AHA/WHF Task Force for the Redefinition of Myocardial Infarction Universal definition of myocardial infarction. J Am Coll Cardiol 2007, 50:2173.
4. Wu A.H., Apple F.S., Gibler W.B., et al. National Academy of Clinical Biochemistry Standards of Laboratory Practice: recommendations for the use of cardiac markers in coronary artery diseases. Clin Chem 1999, 45:1104.
5. Silent Myocardial Ischemia. UpToDate.
6. Mosca L., Appel L.J., Benjamin E.J., American Heart Association, et al. Evidence-based guidelines for cardiovascular disease prevention in women. Circulation 2004, 109:679.
7. Dubach P., Froelicher V.F., Klein J., et al. Exercise-induced hypotension in a male population. Criteria, causes, and prognosis. Circulation 1988, 78:1380.
8. Weiss S.A., Blumenthal R.S., Sharrett A.R., et al. Exercise, blood pressure and future cardiovascular death in asymptomatic individuals. Circulation 2010, 121:2109.
9. Lee T.H., Boucher C.A. Clinical practice. Noninvasive tests in patient with stable coronary artery disease. N Engl J Med 2001, 344(24):1840-1845. [review].
10. Agatston A.S., Janowitz W.R., Hildner F.J., et al. Quantification of coronary artery calcium using ultrafast computed tomography. J Am Coll Cardiol 1990, 15(4):827-832.
11. DeWood J., Spores J., Notske R., et al. Prevalence of total coronary occlusion during the early hours of transmural MI. N Engl J Med 1980, 303:898-902.
12. GUSTO trial results. American Federation of Clinical Research. Clin Res 1993, 41:207-208.
13. Thrombolytic Therapy for acute MI. Lancet 1996, 348:771.
14. Lopex-Sendon J., Swedberg K., McMurray J., et al. Expert consensus document on beta-adrenergic receptor blockers. Eur Heart J 2004, 25:1341.
15. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet 1994, 344:1383.
16. Cannon C.P., Braunwald E., McCabe C.H., et al. Intensive versus moderate lipid lowering with statins after acute coronary syndromes. N Engl J Med 2004, 350:1495.
17. Hillis D.L., Smith P.K., Anderson J.L., et al. 2011 ACCF/AHA Guideline for Coronary Artery Bypass Graft Surgery: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation 2011, 124(23):e652-e735.
18. Aranki S, Aroesty JM, Suri RM. Early noncardiac complications of coronary artery bypass graft surgery. UpToDate. Available at: Accessed August 14, 2012. http://http//www.uptodate.com/contents/early-noncardiac-complications-of-coronary-artery-bypass-graft-surgery%3Fsource=search%20results%26selectedTitle1-150.
19. Slezak J., Tribulova N., Okruchlicovva L., et al. Hibernating myocardium: pathophysiology, diagnosis, and treatment. Can J Physiol Pharmacol 2009, 87(4):252-265.
20. " Clinical research." Cardiac angiogenesis: four approaches to restoring cardiac function 2012, Columbia University medical Center, Department of Surgery, Available at:, Accessed July 24, 2012. http://www.columbiasurgery.org/pat/cardiac/angiogenesis.html.